← Leaderboards
Barbara Jane Coffey
Mc Lean Hospital (Belmont, Ma)
$1,448,318
Attributed
$2,035,700
Total exposure
12
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $735.4K · FY2005–23$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$2,035,700 · 12
By mechanism
R01$970,104 · 2
R21$894,723 · 2
K08$149,654 · 1
M01$21,219 · 7
Top collaborators
- Marco Bortolato4 shared
- Bennett L Leventhal3 shared
Most similar at Mc Lean Hospital (Belmont, Ma)
Same institution · by research overlap
- Perry Franklin Renshaw$32,457,935
- Ross J Baldessarini$317,774
Others in their field
Top investigators on “Child”
- Barbara Driver · Westat, Inc.$244,454,458
- Sharon A Nachman · Johns Hopkins University$212,395,175
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$195,214,889
- George R Seage · Abt Associates, Inc.$189,009,744
- Carol Nesel · Westat$188,148,170
- Elizabeth A Thom · George Washington University$170,579,744
Research focus
ChildGilles De La Tourette SyndromeAffectFundingVariantFamilySamplingSourceCommunitiesVocal TicsMolecularBaseObsessive-Compulsive DisorderAttention Deficit Hyperactivity DisorderGenomicsMotor TicsSeveritiesGenesBiocompatible MaterialsParentsResearch PersonnelGene DiscoveryComorbidityInternational
Grant awards (21)
Exploring the role of neuroactive steroids in Tourette syndrome$196,719
R21 · FY2023 · NS
Exploring the role of microbiota and inflammation in tic fluctuations$192,188
R21 · FY2023 · NS
Exploring the role of neuroactive steroids in Tourette syndrome$262,191
R21 · FY2022 · NS
Exploring the role of microbiota and inflammation in tic fluctuations$243,625
R21 · FY2022 · NS
7/7-Collaborative genomic studies of Tourette Disorder$115,125
R01 · FY2022 · MH · contact PI
7-7-Collaborative genomic studies of Tourette Disorder$114,437
R01 · FY2022 · MH · contact PI
7/7-Collaborative genomic studies of Tourette Disorder$115,125
R01 · FY2021 · MH · contact PI
7/7-Collaborative genomic studies of Tourette Disorder$115,125
R01 · FY2020 · MH · contact PI
7/7-Collaborative genomic studies of Tourette Disorder$115,125
R01 · FY2019 · MH · contact PI
7/7-Collaborative genomic studies of Tourette Disorder$115,125
R01 · FY2018 · MH · contact PI
8/8-Collaborative Genomic Studies of Tourette Disorder$79,641
R01 · FY2013 · MH · contact PI
8/8-Collaborative Genomic Studies of Tourette Disorder$100,334
R01 · FY2012 · MH · contact PI
8/8-Collaborative Genomic Studies of Tourette Disorder$100,067
R01 · FY2011 · MH · contact PI
ARIPIPRAZOLE IN CHILDREN AND ADOLESCENTS WITH TOURETTE'S DISORDER$948
M01 · FY2008 · RR · contact PI
ARIPIPRAZOLE IN CHILDREN AND ADOLESCENTS WITH TOURETTE'S DISORDER$5,128
M01 · FY2007 · RR · contact PI
ARIPIPRAZOLE IN TOURETTE'S DISORDER AND EXPLOSIVE OUTBURSTS$3,945
M01 · FY2007 · RR · contact PI
TREATMENT OF ADOLESCENT SUICIDE ATTEMPTERS (TASA)$2,761
M01 · FY2007 · RR · contact PI
TREATMENT OF ADOLESCENT SUICIDE ATTEMPTERS (TASA)$4,676
M01 · FY2006 · RR · contact PI
ARIPIPRAZOLE IN CHILDREN AND ADOLESCENTS WITH TOURETTE'S DISORDER$2,806
M01 · FY2006 · RR · contact PI
TREATMENT OF ADOLESCENT SUICIDE ATTEMPTERS (TASA)$955
M01 · FY2005 · RR
TOURETTES DISORDER IN CHILDREN--PROSPECTIVE FOLLOWUP$149,654
K08 · FY2000 · MH